Access to funding the main barrier to life sciences innovation
Life sciences companies in Europe believe access to funding is the biggest barrier to innovation in their sector, a study commissioned by international law firm Pinsent Masons has found.
Life sciences companies in Europe believe access to funding is the biggest barrier to innovation in their sector, a study commissioned by international law firm Pinsent Masons has found.